[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:ovarian-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":206,"states":207},"Ovarian Carcinoma",32,29,[8,16,23,30,36,42,48,54,61,67,73,79,85,91,97,103,109,115,120,126,132,138,144,150,156,162,168,174,180,186,193,200],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06819007","Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)",[12],"Phase 3","RECRUITING","2026-08-26T02:18:27.904411Z","2026-05-05T02:43:28.293021Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06469281","A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers",[20],"Phase 1","2026-08-26T02:17:10.213717Z","2026-05-05T02:43:29.649784Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT05538091","Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer",[27],"Phase 2","2026-08-26T02:18:23.582895Z","2026-05-05T02:43:29.380981Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT07218809","AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer",[12],"2026-08-26T02:16:23.080181Z","2026-05-05T02:43:29.327362Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06915025","Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w\u002F Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w\u002F Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer",[12],"2026-08-26T02:17:50.500039Z","2026-05-05T02:43:28.985522Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06890338","A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.",[27],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.627515Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT07495124","IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence",[27],"2026-08-26T02:16:01.910993Z","2026-05-05T02:43:26.726342Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":59,"content_modified":60},"NCT07186842","A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9",[58],"Phase 1\u002FPhase 2","2026-08-26T02:15:27.567165Z","2026-07-19T19:36:05.067561Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT05579366","Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01\u002F PRO1184-001)",[58],"2026-08-26T02:17:02.694423Z","2026-07-05T05:32:16.807199Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT04969835","A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours",[20],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:29.397013Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT05867251","Study of AVZO-021 in Patients With Advanced Solid Tumors",[58],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:29.354579Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT04851119","Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors",[58],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:29.139986Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06270706","A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors",[20],"2026-08-26T02:18:44.395098Z","2026-05-05T02:43:28.480860Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT06172478","A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors",[27],"2026-08-26T02:17:26.640202Z","2026-05-05T02:43:28.357224Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT05092373","Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax",[20],"2026-08-26T02:17:12.307088Z","2026-05-05T02:43:27.097111Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[27],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT04282044","Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies",[20],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:26.932270Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":46,"content_modified":119},"NCT05733000","CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors",[27],"2026-05-05T02:43:26.767445Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT07432633","[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications",[58],"2026-08-26T02:19:05.360997Z","2026-07-05T05:32:16.681623Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT05564377","Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial",[27],"2026-08-26T02:18:33.598205Z","2026-05-05T02:43:29.493283Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT07489287","GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer",[20],"2026-08-26T02:16:35.654046Z","2026-06-14T18:39:22.247991Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT06295965","Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study",[],"2026-08-26T02:19:06.150683Z","2026-05-13T02:55:06.433546Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT05059444","ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation",[],"2026-08-26T02:19:10.436356Z","2026-05-13T02:55:06.282815Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT07282158","Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians",[],"2026-08-26T02:19:18.331180Z","2026-05-05T02:43:29.411698Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT06386887","Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer",[],"2026-08-26T02:17:36.611194Z","2026-05-05T02:43:27.600690Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT07285044","The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas",[27],"2026-08-26T02:16:24.135291Z","2026-07-05T05:32:16.672723Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT06492070","Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers",[27],"2026-08-26T02:15:59.318403Z","2026-05-05T02:43:28.010313Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT06412510","Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w\u002F NACT",[58],"2026-08-26T02:18:38.077159Z","2026-05-05T02:43:26.977838Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":184,"content_modified":185},"NCT03245411","Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients",[],"2026-08-26T02:18:31.944757Z","2026-05-05T02:43:26.928781Z",{"nct_id":187,"title":188,"phases":189,"status":190,"updated_at":191,"content_modified":192},"NCT07265739","Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer",[27],"NOT_YET_RECRUITING","2026-08-26T02:17:54.420226Z","2026-04-29T02:57:57.069901Z",{"nct_id":194,"title":195,"phases":196,"status":197,"updated_at":198,"content_modified":199},"NCT06781983","Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:47:53.324478Z","2026-05-05T02:43:27.424580Z",{"nct_id":201,"title":202,"phases":203,"status":197,"updated_at":204,"content_modified":205},"NCT07118176","Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers",[20],"2026-08-03T03:24:20.303158Z","2026-05-05T02:43:28.732453Z",[],[208,212,216,220,224,227,231,234,238,241,244,248,251,254,257,261,264,267,270,273,276,280,283,287],{"state":209,"count":210,"slug":211},"New York",14,"new-york",{"state":213,"count":214,"slug":215},"Texas",13,"texas",{"state":217,"count":218,"slug":219},"Florida",12,"florida",{"state":221,"count":222,"slug":223},"Pennsylvania",11,"pennsylvania",{"state":225,"count":222,"slug":226},"Washington","washington",{"state":228,"count":229,"slug":230},"California",10,"california",{"state":232,"count":229,"slug":233},"Ohio","ohio",{"state":235,"count":236,"slug":237},"Massachusetts",9,"massachusetts",{"state":239,"count":236,"slug":240},"Minnesota","minnesota",{"state":242,"count":236,"slug":243},"New Jersey","new-jersey",{"state":245,"count":246,"slug":247},"Illinois",7,"illinois",{"state":249,"count":246,"slug":250},"Oregon","oregon",{"state":252,"count":246,"slug":253},"Tennessee","tennessee",{"state":255,"count":246,"slug":256},"Virginia","virginia",{"state":258,"count":259,"slug":260},"Georgia",6,"georgia",{"state":262,"count":259,"slug":263},"Maryland","maryland",{"state":265,"count":259,"slug":266},"Michigan","michigan",{"state":268,"count":259,"slug":269},"Missouri","missouri",{"state":271,"count":259,"slug":272},"North Carolina","north-carolina",{"state":274,"count":259,"slug":275},"Utah","utah",{"state":277,"count":278,"slug":279},"Alabama",5,"alabama",{"state":281,"count":278,"slug":282},"Indiana","indiana",{"state":284,"count":285,"slug":286},"Arizona",4,"arizona",{"state":288,"count":285,"slug":289},"Colorado","colorado"]